European banks are on the up and up. And President Donald Trump has thrown spikes on the road for US climate policy. Plus, mining companies in Africa’s Sahel region are being targeted. Aanu Adeoye ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

OpenAI’s development of an “agent” to automate the work of a senior software engineer—which my colleagues scooped yesterday—will raise the stakes in an already competitive market for AI coding tools.

Isomorphic Labs, Johnson & Johnson, MSD, Novo Nordisk, Pfizer, Regeneron, and Takeda. The data will be made available to scientists worldwide, providing they have a suitable research project for ...